Tryptase Place · Alpha-Link
HαT is a copy-number variant of the tryptase gene that turns up the volume on the mast cell system — and follows the body wherever mast cells live: brain, vessels, gut, bone, barrier.
Hypothesis · Open Call
What if ADHD and autism share an upstream driver we've been missing — and the protocol that's moving the needle in early Alzheimer's could move it here too?
A 2025 precision medicine RCT in early cognitive decline reported 5–7× improvements in neuroinflammatory outcomes where standard care declined — by treating root causes instead of symptoms.
ADHD carries an inflammation signal. Autism carries a mast cell signal. Both run through the same neighborhood. HαT provides a genetically identifiable, measurable upstream driver of exactly the microglial dysfunction that defines both.
HαT turns up the mast cell volume system-wide — including the brain's. A $50 basal serum tryptase identifies carriers. BST has never been measured in treatment-resistant ADHD or ASD cohorts.
Every piece of this exists in the literature. The bundle has never been tested in ADHD or ASD. That's the gap. That's the ask.
Not medical advice. A call for a trial, not a treatment claim.
Research Gap 29–35 · The Copper Axis
Copper is not a peripheral detail. It is an essential cofactor for four independent mechanisms that each directly compound HαT severity — none of which have been studied in HαT-confirmed cohorts.
Copper-dependent enzyme that crosslinks collagen and elastin into mechanically strong matrices. Low copper → LOX fails → collagen synthesized but not crosslinked → structurally weak tissue that cannot resist chronic tryptase-driven proteolysis. Same mechanism confirmed in keratoconus corneas (2.5× lower LOX activity) and progressive myopia.
Copper inversely regulates the MITF transcription factor and its downstream target, the tryptase gene, via ERK1/2 signaling. Copper sufficiency suppresses tryptase gene transcription. Copper deficiency removes this brake — tryptase-positive mast cell numbers expand. In HαT carriers, this amplifies an already constitutively elevated tryptase burden.
Diamine oxidase is the primary enzyme responsible for degrading histamine in intestinal tissue and plasma — and it is copper-dependent. Low copper impairs DAO activity. In HαT carriers already producing excess mast cell-derived histamine, copper-insufficient DAO means histamine accumulates from two directions simultaneously: excess production and impaired clearance.
DBH is the cuproenzyme that converts dopamine to norepinephrine in sympathetic nerve terminals. Low copper impairs DBH → reduced norepinephrine synthesis → autonomic dysregulation clinically indistinguishable from POTS. Copper deficiency also reduces tyrosine hydroxylase neurons in the dorsal motor nucleus of the vagus — the brainstem's parasympathetic brake — the same structure HαT neuroinflammation is already compromising.
Copper deficiency worsens HαT. HαT does not predictably deplete copper — inflammation tends to raise serum copper via ceruloplasmin upregulation. Serum copper alone is insufficient to assess status in an inflamed HαT carrier. The correct panel is: serum copper + ceruloplasmin + RBC copper/SOD activity + serum zinc + DAO activity. RBC copper is the most sensitive functional marker. Zinc supplementation — common in MCAS self-management — competitively depletes copper and may be inadvertently worsening mast cell reactivity via MITF derepression.
The copper panel that starts to answer this:
One blood draw. The study does not exist. Yet.
Each one testable. Most requiring only a $50 blood draw and the will to ask the question.
"Tryptase starts the fire.
HMGB1 is the smoke that chokes the brain's ability to regulate emotion."
The Generational Load · Tryptase Place · v12, 2026
If your symptoms keep spilling past the diagnoses you've been given — ADHD, POTS, hypermobility, treatment-resistant depression — start here. The Sentinel Guide maps the cascade and the treatment stack.
Patient guide →A working framework for recognizing HαT-driven multi-system disease. What to order, how to interpret it, and why serum copper alongside BST changes the picture.
Clinical brief →35 research gaps. A hypothesis paper timestamped on OSF. A Sentinel Initiative briefing designed for ARPA-H Program Managers. We are seeking a Scientific PI.
Get in touch →
Tryptase Place started in a kitchen, with a mother, a notebook, and a stack of symptoms
that no single specialty would claim. It exists now because the science keeps catching up —
and because the people living this deserve maps, not maybes.
The screening test exists. The cost is under $50. The cycle ends here.